Folic Acid
$ 6,00 – $ 18,00Price range: $ 6,00 through $ 18,00
Forxiga
$ 52,00 – $ 340,00Price range: $ 52,00 through $ 340,00
Foracort Inhaler
$ 47,00 – $ 345,00Price range: $ 47,00 through $ 345,00
Foracort Inhaler is a highly effective combination medication specifically formulated to manage chronic respiratory conditions such as asthma and COPD. This inhaler utilizes two active ingredients, Budesonide and Formoterol, to reduce airway inflammation and prevent the muscles around the airways from tightening. It serves as a reliable maintenance therapy, providing long-term control to help patients breathe more easily and consistently. Regular use helps significantly reduce the frequency of symptoms like wheezing, coughing, and shortness of breath. By enhancing overall lung function, Foracort Inhaler supports a more active and comfortable daily life for those with respiratory challenges.
Active substance: Budesonide, Formoterol
SKU:
Foracort Inhaler
Category: Asthma
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Foracort Inhaler belongs to a class of combination respiratory medications containing an inhaled corticosteroid (budesonide) and a long-acting beta2-adrenergic agonist (formoterol fumarate dihydrate). It is prescribed for the long-term maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in accordance with federal regulations governing prescription pharmaceutical agents.
The therapy is designed to lower airway inflammation while simultaneously relaxing smooth muscles in the pulmonary tract to improve airflow. Proper inhalation technique and adherence to a prescribed daily schedule are critical to achieving optimal therapeutic efficacy and maintaining control over chronic symptoms.
| Property | Specification |
|---|---|
| Active ingredients | Budesonide and Formoterol fumarate dihydrate |
| Therapeutic class | Inhaled corticosteroid / Long-acting beta2-adrenergic agonist (ICS/LABA) |
| Dosage form | Metered-dose inhalation aerosol / powder |
| Route of administration | Oral inhalation |
| Primary purpose | Maintenance therapy for asthma and COPD management |
| Prescription status | Prescription only (Rx) |
Clinical Overview and Pharmacological Profile
Mechanism of action
Budesonide is a potent potent synthetic corticosteroid displaying local anti-inflammatory activity within the respiratory epithelium. It inhibits multiple inflammatory cell types, including mast cells, eosinophils, neutrophils, and lymphocytes, while diminishing cytokine production and release. Formoterol fumarate dihydrate operates as a selective long-acting beta2-adrenergic receptor agonist. Upon pulmonary inhalation, formoterol stimulates intracellular adenyl cyclase, catalyzing the conversion of adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP). Elevated cAMP levels induce relaxation of bronchial smooth muscle, alleviating bronchoconstriction and reducing airway hyperresponsiveness.
Main uses
The primary clinical indication for this combination inhalation product is the long-term maintenance treatment of asthma in patients aged 6 years and older when combination therapy is deemed clinically appropriate. Additionally, it is indicated for the maintenance treatment of airflow limitation in individuals diagnosed with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. This medication is not indicated for the acute relief of sudden bronchospasm when fast-acting rescue bronchodilators are required, unless prescribed under a specific single-inhaler maintenance and reliever therapy regimen authorized by a licensed prescriber. Off-label indications must be evaluated exclusively by a healthcare professional.
Dosing schedule
Dosage requirements must be individualized based on clinical severity and patient response under professional medical supervision. Standard administration involves two oral inhalations twice daily, taken approximately 12 hours apart in the morning and evening. Patients are advised to perform oral rinsing with water without swallowing after each administration session to decrease the incidence of local adverse effects. Adjustments to dosage strength or administration frequency should occur strictly under clinical guidance, and abrupt discontinuation of therapy without medical direction should be avoided.
How the drug is absorbed and eliminated
Following oral inhalation, budesonide is rapidly absorbed into mucosal surfaces, reaching peak plasma concentrations within 20 to 30 minutes. Systemic bioavailability is approximately 10% to 30% of the nominal dose, with plasma protein binding recorded at roughly 88%. Budesonide undergoes extensive first-pass hepatic metabolism via the cytochrome P450 CYP3A4 enzyme pathway, converting to low-potency metabolites cleared via renal and biliary routes. Formoterol exhibits rapid pulmonary absorption, exerting bronchodilatory effects within 1 to 3 minutes post-inhalation. Systemic plasma protein binding of formoterol ranges between 61% and 64%. It is eliminated primarily through hepatic glucuronidation and O-demethylation, demonstrating a terminal elimination half-life of approximately 10 to 14 hours.
Compatibility with other medicines
Concomitant administration of potent cytochrome P450 3A4 inhibitors, such as ketoconazole, itraconazole, clarithromycin, or ritonavir, can significantly increase systemic exposure to budesonide, elevating the risk of systemic corticosteroid adverse effects. Co-administration with non-selective beta-adrenergic blockers, including propranolol, can attenuate or block the therapeutic effects of formoterol and potentially precipitate severe bronchospasm in susceptible asthmatic patients. Concomitant use with other sympathomimetic agents may potentiate cardiovascular side effects. Caution is warranted when combining formoterol with drugs known to prolong the QTc interval, such as certain antiarrhythmics, tricyclic antidepressants, and phenothiazines, due to an increased risk of ventricular arrhythmias.
Adverse reactions
Adverse effects associated with inhaled budesonide and formoterol range from localized mucosal responses to systemic pharmacological events. Frequently observed local side effects include oral candidiasis (thrush), dysphonia (hoarseness), pharyngolaryngeal irritation, and transient cough. Systemic effects related to beta2-agonist exposure may include fine muscle tremor, headache, palpitations, tachycardia, and mild hypokalemia. Prolonged administration of high-dose inhaled corticosteroids carries potential risks of bone mineral density reduction, cataract formation, elevated intraocular pressure, and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Paradoxical bronchospasm may occur immediately following administration and requires instantaneous intervention.
Important precautions
Long-acting beta2-adrenergic agonists used as monotherapy increase the risk of asthma-related hospitalizations and death; however, this risk is mitigated when administered in a fixed-dose combination with an inhaled corticosteroid. Patients presenting with underlying cardiovascular disorders, severe hypertension, coronary artery disease, or cardiac arrhythmias must be monitored closely due to potential sympathomimetic stimulation. Caution should be exercised in individuals with active or latent pulmonary tuberculosis, or untreated systemic fungal, bacterial, or viral infections, as corticosteroids may mask signs of infection or cause immunosuppression. Pediatric patients undergoing long-term therapy require periodic assessment of growth velocity.
Practical tips
Correct administration requires proper preparation and execution. Prior to dosing, exhale completely away from the mouthpiece, place the orifice securely between the lips, and inhale deeply and steadily while actuating the device. Hold breath for up to 10 seconds to maximize deep pulmonary deposition. Keep the inhaler clean by wiping the mouthpiece with a dry cloth; water should not be used directly on the device container. Always perform a thorough mouth rinse with water after every inhalation session, spitting out the water completely to lower the incidence of localized fungal infections.
If you skip a dose
If a regular scheduled dose is missed, administer the next planned dose at the usual scheduled time. Do not double the dose or take additional inhalations to make up for a missed dose. Consistent twice-daily administration helps maintain steady therapeutic levels necessary for ongoing pulmonary control.
Red flags
Immediate medical attention is warranted if sudden, severe dyspnea or acute paradoxical bronchospasm occurs following inhalation. Patients should seek emergency medical assistance if experiencing symptoms indicative of severe hypersensitivity reactions (such as facial, lip, tongue, or throat edema, or acute respiratory distress), severe chest pain, irregular or rapid heart rhythms, or a sudden deterioration of respiratory status that fails to respond to quick-relief rescue medication.
Storage and expiration
Store the inhaler at room temperature, ideally between 68°F and 77°F (20°C to 25°C), away from direct sunlight, excessive heat, and moisture. The canister contains pressurized liquid and must not be exposed to temperatures exceeding 120°F (49°C) or open flames. Do not puncture or incinerate the container. Keep out of reach of children. Safely discard the inhalation unit once the expiration date printed on the packaging or built-in dose counter has passed.
Frequently Asked Questions
How quickly does the inhaler work to improve airflow?
The formoterol component begins relaxing smooth bronchial muscles quickly, with bronchodilatory activity typically starting within 1 to 3 minutes after inhalation. However, the anti-inflammatory benefits provided by the budesonide component develop gradually over several days to weeks of continuous, routine administration. The medication must be taken consistently as prescribed to maintain baseline control over chronic respiratory symptoms.
Why is rinsing the mouth required after each dose?
Rinsing the mouth with water and spitting it out after every inhalation session removes residual corticosteroid particles deposited on the oral mucosa and pharynx. This precaution significantly decreases the likelihood of developing local fungal infections, such as oral candidiasis (thrush), as well as throat irritation and vocal cord dysfunction (hoarseness).
Can this medication be used concurrently with blood pressure drugs?
Certain blood pressure medications, specifically non-selective beta-blockers such as propranolol, can interfere with the pharmacological action of formoterol and may trigger severe bronchospasm. Patients taking antihypertensive agents should disclose their complete medication list to their treating physician to ensure compatible therapy is selected.
Should treatment be stopped when asthma symptoms resolve?
Therapy should not be discontinued simply because respiratory symptoms have improved or resolved. Chronic asthma and COPD involve ongoing airway inflammation that requires continuous long-term maintenance. Abrupt cessation of inhaled corticosteroids can lead to symptom exacerbations or severe disease flares. Any modification of the treatment plan must be conducted under medical supervision.
This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA requirements.
Additional information
| Dosage |
100mcg+6mcg ,200mcg+6mcg ,400mcg+6mcg |
|---|---|
| Package |
1 inhaler ,2 inhaler ,3 inhaler ,4 inhaler ,5 inhaler ,6 inhaler ,7 inhaler ,8 inhaler ,9 inhaler ,10 inhaler |
| Ενεργός Ουσία | , |
Related products
Astelin
$ 46,00 – $ 193,00Price range: $ 46,00 through $ 193,00
Active substance: Azelastine
More Details
This product has multiple variants. The options may be chosen on the product page
Asthalin Inhaler
$ 50,00 – $ 215,00Price range: $ 50,00 through $ 215,00
Active substance: Salbutamol
More Details
This product has multiple variants. The options may be chosen on the product page
Budecort Inhaler
$ 17,00 – $ 92,00Price range: $ 17,00 through $ 92,00
Active substance: Budesonide
More Details
This product has multiple variants. The options may be chosen on the product page
Claritin
$ 43,00 – $ 143,00Price range: $ 43,00 through $ 143,00
Active substance: Loratadine
More Details
This product has multiple variants. The options may be chosen on the product page
Ketasma
$ 10,00 – $ 23,00Price range: $ 10,00 through $ 23,00
Active substance: Ketotifen Fumarate
More Details
This product has multiple variants. The options may be chosen on the product page
Levolin Inhaler
$ 9,00 – $ 48,00Price range: $ 9,00 through $ 48,00
Active substance: Levosalbutamol
More Details
This product has multiple variants. The options may be chosen on the product page
Omnacortil
$ 51,00 – $ 210,00Price range: $ 51,00 through $ 210,00
Active substance: prednisolone
More Details
This product has multiple variants. The options may be chosen on the product page
Promethazine
$ 43,00 – $ 228,00Price range: $ 43,00 through $ 228,00
Active substance: Promethazine
More Details
This product has multiple variants. The options may be chosen on the product page
